{
  "symbol": "GLSI",
  "company_name": "Greenwich Lifesciences Inc",
  "ir_website": "https://greenwichlifesciences.com/investors/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://investor.greenwichlifesciences.com/news-events/press-releases",
          "content": "[![Greenwich LifeSciences](https://d1io3yog0oux5.cloudfront.net/_28267d1ffe46264b463f6002dbe0a4e9/greenwichlifesciences/files/theme/site-files/20210118/wp-content/uploads/2020/07/20-GLSI-Biopharmaceutical-Company-Full-Logo-Greenwich-LifeSciences.png)](https://greenwichlifesciences.com/)\n\n[ ](#)\n\n# Press Releases\n\nYear All Years 2024 2023 2022 2021 2020\n\nAll Years\n\n  * All Years\n  * 2024\n  * 2023\n  * 2022\n  * 2021\n  * 2020\n\n\n\nNov 26, 2024 6:00am EST\n\n##  [ Greenwich LifeSciences Partners with GIM in Italy ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/86/greenwich-lifesciences-partners-with-gim-in-italy)\n\nNov 18, 2024 6:00am EST\n\n##  [ Greenwich LifeSciences Provides Update on Corporate Events ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/85/greenwich-lifesciences-provides-update-on-corporate-events)\n\nAug 01, 2024 6:00am EDT\n\n##  [ Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/84/greenwich-lifesciences-provides-update-on-expansion-of)\n\nJun 26, 2024 7:33am EDT\n\n##  [ Greenwich LifeSciences Set to Join Russell 2000 Index Again ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/83/greenwich-lifesciences-set-to-join-russell-2000-index-again)\n\nJun 14, 2024 6:00am EDT\n\n##  [ Greenwich LifeSciences Announces $2.5 Million Private Placement ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/82/greenwich-lifesciences-announces-2-5-million-private)\n\nMar 13, 2024 6:00am EDT\n\n##  [ Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/81/greenwich-lifesciences-extends-lock-up-of-directors-and)\n\nMar 12, 2024 6:00am EDT\n\n##  [ Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/80/greenwich-lifesciences-partners-with-geicam-in-spain)\n\nFeb 27, 2024 6:00am EST\n\n##  [ Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/79/greenwich-lifesciences-flamingo-01-phase-iii-clinical-trial)\n\nFeb 22, 2024 6:00am EST\n\n##  [ Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/78/greenwich-lifesciences-flamingo-01-manufacturing-protocol)\n\nFeb 14, 2024 6:00am EST\n\n##  [ Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 ](https://investor.greenwichlifesciences.com/news-events/press-releases/detail/77/greenwich-lifesciences-provides-update-on-phase-iii)\n\n  * [1](https://investor.greenwichlifesciences.com/news-events/press-releases?page=1)\n  * [2](https://investor.greenwichlifesciences.com/news-events/press-releases?page=2)\n  * [3](https://investor.greenwichlifesciences.com/news-events/press-releases?page=3)\n  * [4](https://investor.greenwichlifesciences.com/news-events/press-releases?page=4)\n  * [5](https://investor.greenwichlifesciences.com/news-events/press-releases?page=5)\n  * [6](https://investor.greenwichlifesciences.com/news-events/press-releases?page=6)\n  * [7](https://investor.greenwichlifesciences.com/news-events/press-releases?page=7)\n  * [8](https://investor.greenwichlifesciences.com/news-events/press-releases?page=8)\n  * [Next](https://investor.greenwichlifesciences.com/news-events/press-releases?page=2)\n\n\n\n[ ![RSS](https://d1io3yog0oux5.cloudfront.net/_28267d1ffe46264b463f6002dbe0a4e9/greenwichlifesciences/files/theme/images/rssfeed.gif) ](https://investor.greenwichlifesciences.com/news-events/press-releases/rss)\n\nBy proceeding to use this website, you consent to our use of cookies as described in our [Privacy Policy](https://greenwichlifesciences.com/privacy-policy).\n\nClose\n\n## Email Alerts\n\n[Sign up Now ](#email-alerts-cta-form)\n\nFirst Name\n\nLast Name\n\nEmail Address\n\nContact Type: Individual Investor Analyst Broker/Investment Advisor Portfolio Manager Banker/Financing Source Press/Media Consultant Employee Customer/Client Student Other\n\nIndividual Investor\n\n  * Individual Investor\n  * Analyst\n  * Broker/Investment Advisor\n  * Portfolio Manager\n  * Banker/Financing Source\n  * Press/Media\n  * Consultant\n  * Employee\n  * Customer/Client\n  * Student\n  * Other\n\n\n\nSign me up for:\n\nAll Press Releases\n\nAll SEC Filings\n\n10-K & 10-Q Reports\n\nCurrent Reports\n\nInsider Transactions\n\nProxy Information\n\nSubmit\n\n  * [Tear Sheet](https://d1io3yog0oux5.cloudfront.net/_28267d1ffe46264b463f6002dbe0a4e9/greenwichlifesciences/files/GLSI+Tear+Sheet.pdf \"Tear Sheet\")\n  * [RSS Feed](https://investor.greenwichlifesciences.com/news-events/press-releases/rss)\n\n\n"
        }
      ]
    }
  ]
}